Zenas Biopharma, Inc. valuation and forecast
Explore the models for Zenas Biopharma, Inc., adjust their assumptions and compare your own valuation with the platform's.
Stock price today
Loading chart…
Third-party market data · may be delayed
Fair value per share
Under review: every model's value for Zenas Biopharma, Inc. is far from the share price, which usually points to a data problem (a merger, a share-count change, a one-off) rather than a bargain or a bubble.
Price vs value
Under review: data-quality checks not passed. We'll show the comparison once resolved.
Analyst recommendations
Monthly trend
- Oct 20268
- Sep 20268
- Aug 20268
- Jul 20268
Counts of recommendations published by analysts covering Zenas Biopharma, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.
Price history
Loading chart…
Third-party market data · may be delayed
ZBIO valuation questions
- How does Fundamentalytics value Zenas Biopharma, Inc.?
- We use the models that fit Zenas Biopharma, Inc.'s business and available financial data. Each model has its own assumptions and data requirements. The calculator explains which models are available and lets you adjust their inputs.
Data: SEC EDGAR filings, retrieved November 1, 2026. Method: how we value companies. Disclosures: research and recommendations disclosure. Back to Zenas Biopharma, Inc.